Molecular Diagnostics Market by Product & Services (Reagents and Kits, Instruments, and Software and Services), by Application (Genetic Tests, Infectious Diseases, Oncology, and Others), by Technology (PCR, INAAT, DNA Sequencing & NGS, In Situ Hybridization, DNA Microarrays, and Others), and by End-User (Diagnostic Laboratories, Hospitals, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

                                          
Abstract
                    
The report covers a forecast and an analysis of the molecular diagnostics market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the molecular diagnostics market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the molecular diagnostics market on a global level.

In order to give the users of this report a comprehensive view of the molecular diagnostics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.

The study provides a decisive view of the molecular diagnostics market by segmenting it on the basis of product and services, application, technology, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., UK, Germany, France, China, Japan, India, Brazil, etc.

Some major players of the global molecular diagnostics market are Becton Dickinson, Abbott Laboratories, Roche Diagnostics, Novartis, Johnson and Johnson, bioMerieux, Bio-Rad Laboratories, Qiagen NV, Siemens Healthcare, Danaher Corporation, and Hologic.

This report segments the global molecular diagnostics market into:

Global Molecular Diagnostics Market: Product and Services Analysis

	Reagents and Kits
	Instruments
	Software and Services

Global Molecular Diagnostics Market: Application Analysis

	Genetic Tests
	Infectious Diseases


	Hepatitis
	HIV
	CT/NG
	HPV
	TB
	Influenza
	Others


	Oncology


	Breast Cancer
	Lung Cancer
	Colorectal Cancer
	Prostate Cancer
	Other Cancers


	Others

Global Molecular Diagnostics Market: Technology Analysis

	Polymerase Chain Reaction (PCR)
	Isothermal Nucleic Acid Amplification Technology (INAAT)
	DNA Sequencing and Next Generation Sequencing (NGS)
	In Situ Hybridization
	DNA Microarrays
	Others

Global Molecular Diagnostics Market: End-User Analysis

	Diagnostic Laboratories
	Hospitals
	Others

Global Molecular Diagnostics Market: Regional Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa